Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
24 participants
OBSERVATIONAL
2010-12-01
2017-02-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Colonization, Infection, and Molecular Typing of Methicillin-Resistant Staphylococcus Aureus (MRSA) in Children.
NCT00254527
Evaluation of the Efficacy of Streptococcus Salivarius Evol12® in the Reduction of Recurrent Adenotonsillitis in Children
NCT07235826
Molecular Epidemiology of Streptococcus Pyogenes Among Children in Bamako, Mali
NCT00305123
Survey of the Facial Bacteriome
NCT04180748
Role of the NLRP3 Inflammasome in Escherichia Coli and Staphylococcus Aureus Bacteria
NCT03869593
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
No tonsilar or adenoid problems
No interventions assigned to this group
Adenotonsillectomy (recurrent)
Recurrent adenotonsillitis
No interventions assigned to this group
Adenotonsillectomy (obstruction)
Upper airway obstruction
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Both males and females
* Undergoing adenotonsillectomy
Additional criteria for subjects in the recurrent infection group:
* Sleep questionnaire score \<5
* Designated by surgeon as having recurrent adenotonsillitis as reason for surgery
Additional criteria for subjects in the airway obstruction group:
* Sleep questionnaire score \>5
* Presence of positive polysomnogram desired but not necessary
* Designated by surgeon as having airway obstruction or sleep apnea as reason for surgery
* Age 2-12 yrs
* Both males and females
* No history of adenotonsillar problems
* Sleep questionnaire score \< 5
Exclusion Criteria
* Other major medical problems (immune deficiency, cystic fibrosis, malignancy) In the surgery group: designated by surgeon as having both recurrent adenotonsillitis and airway obstruction as reason for surgery Menstruating females
2 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Chicago
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fuad M Baroody, MD
Role: PRINCIPAL_INVESTIGATOR
University of Chicago
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Chicago
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10-636-A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.